These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 28799854)

  • 61. Metal concentrations in cerebrospinal fluid and blood plasma from patients with amyotrophic lateral sclerosis.
    Roos PM; Vesterberg O; Syversen T; Flaten TP; Nordberg M
    Biol Trace Elem Res; 2013 Feb; 151(2):159-70. PubMed ID: 23225075
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cystatin C in cerebrospinal fluid as a biomarker of ALS.
    Tsuji-Akimoto S; Yabe I; Niino M; Kikuchi S; Sasaki H
    Neurosci Lett; 2009 Mar; 452(1):52-5. PubMed ID: 19444952
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evidence for fungal infection in cerebrospinal fluid and brain tissue from patients with amyotrophic lateral sclerosis.
    Alonso R; Pisa D; Marina AI; Morato E; Rábano A; Rodal I; Carrasco L
    Int J Biol Sci; 2015; 11(5):546-58. PubMed ID: 25892962
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Analyzing Cerebrospinal Fluid Proteomes to Characterize Central Nervous System Disorders: A Highly Automated Mass Spectrometry-Based Pipeline for Biomarker Discovery.
    Núñez Galindo A; Macron C; Cominetti O; Dayon L
    Methods Mol Biol; 2019; 1959():89-112. PubMed ID: 30852817
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Preparation of human cerebrospinal fluid for proteomics biomarker analysis.
    Waybright TJ
    Methods Mol Biol; 2013; 1002():61-70. PubMed ID: 23625394
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mass spectrometry analysis of plasma from amyotrophic lateral sclerosis and control subjects.
    Xu Z; Lee A; Nouwens A; Henderson RD; McCombe PA
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Aug; 19(5-6):362-376. PubMed ID: 29384411
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Chitinases as a potential diagnostic and prognostic biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis.
    Xu A; Luo Y; Tang Y; Yang F; Gao X; Qiao G; Zhu X; Zhou J
    Neurol Sci; 2024 Jun; 45(6):2489-2503. PubMed ID: 38194198
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Decreased cerebrospinal fluid cytochrome c levels in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Scand J Clin Lab Invest; 2007; 67(3):264-9. PubMed ID: 17454840
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis.
    Vu LT; Bowser R
    Neurotherapeutics; 2017 Jan; 14(1):119-134. PubMed ID: 27933485
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In-Depth Cerebrospinal Fluid Quantitative Proteome and Deglycoproteome Analysis: Presenting a Comprehensive Picture of Pathways and Processes Affected by Multiple Sclerosis.
    Kroksveen AC; Guldbrandsen A; Vaudel M; Lereim RR; Barsnes H; Myhr KM; Torkildsen Ø; Berven FS
    J Proteome Res; 2017 Jan; 16(1):179-194. PubMed ID: 27728768
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antioxidant capacity and protein oxidation in cerebrospinal fluid of amyotrophic lateral sclerosis.
    Siciliano G; Piazza S; Carlesi C; Del Corona A; Franzini M; Pompella A; Malvaldi G; Mancuso M; Paolicchi A; Murri L
    J Neurol; 2007 May; 254(5):575-80. PubMed ID: 17426914
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Multicentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosis.
    Lehnert S; Costa J; de Carvalho M; Kirby J; Kuzma-Kozakiewicz M; Morelli C; Robberecht W; Shaw P; Silani V; Steinacker P; Tumani H; Van Damme P; Ludolph A; Otto M
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep; 15(5-6):344-50. PubMed ID: 24575871
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Differential diagnosis of amyotrophic lateral sclerosis from Guillain-Barré syndrome by quantitative determination of TDP-43 in cerebrospinal fluid.
    Hosokawa M; Arai T; Yamashita M; Tsuji H; Nonaka T; Masuda-Suzukake M; Tamaoka A; Hasegawa M; Akiyama H
    Int J Neurosci; 2014 May; 124(5):344-9. PubMed ID: 24066851
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Assessment of a multiple biomarker panel for diagnosis of amyotrophic lateral sclerosis.
    Chen X; Chen Y; Wei Q; Ou R; Cao B; Zhao B; Shang HF
    BMC Neurol; 2016 Sep; 16():173. PubMed ID: 27634542
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Expression of vesicle-associated membrane-protein-associated protein B cleavage products in peripheral blood leukocytes and cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis.
    Deidda I; Galizzi G; Passantino R; Cascio C; Russo D; Colletti T; La Bella V; Guarneri P
    Eur J Neurol; 2014 Mar; 21(3):478-85. PubMed ID: 24372953
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Proteomics and mathematical modeling of longitudinal CSF differentiates fast versus slow ALS progression.
    Vu L; Garcia-Mansfield K; Pompeiano A; An J; David-Dirgo V; Sharma R; Venugopal V; Halait H; Marcucci G; Kuo YH; Uechi L; Rockne RC; Pirrotte P; Bowser R
    Ann Clin Transl Neurol; 2023 Nov; 10(11):2025-2042. PubMed ID: 37646115
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Metabolomics in cerebrospinal fluid of patients with amyotrophic lateral sclerosis: an untargeted approach via high-resolution mass spectrometry.
    Blasco H; Corcia P; Pradat PF; Bocca C; Gordon PH; Veyrat-Durebex C; Mavel S; Nadal-Desbarats L; Moreau C; Devos D; Andres CR; Emond P
    J Proteome Res; 2013 Aug; 12(8):3746-54. PubMed ID: 23859630
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cerebrospinal fluid tau protein is not a biological marker in amyotrophic lateral sclerosis.
    Paladino P; Valentino F; Piccoli T; Piccoli F; La Bella V
    Eur J Neurol; 2009 Feb; 16(2):257-61. PubMed ID: 19138331
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
    Boylan KB; Glass JD; Crook JE; Yang C; Thomas CS; Desaro P; Johnston A; Overstreet K; Kelly C; Polak M; Shaw G
    J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):467-72. PubMed ID: 23117489
    [TBL] [Abstract][Full Text] [Related]  

  • 80. MicroRNAs as Biomarkers in Amyotrophic Lateral Sclerosis.
    Ricci C; Marzocchi C; Battistini S
    Cells; 2018 Nov; 7(11):. PubMed ID: 30463376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.